Skip to content
All resources

Testing, quality and handling

Third-party peptide testing in Canada: how to judge a vendor's testing programme

NB

By

· 10 min read

A summary of published research, with citations. It states no amount, schedule or route, and makes no claim about what this compound does in a person. Supplied for laboratory research use only.

On this page · 8 sections
  1. What "third-party" does and does not mean
  2. Which tests a complete programme covers
  3. What ISO/IEC 17025 accreditation means
  4. Per-lot testing versus one-off testing
  5. Who chooses the sample
  6. The Canadian regulatory context
  7. Questions to put to any vendor
  8. Frequently asked questions

Third-party peptide testing means a laboratory independent of the seller analyses samples of each lot and issues its own report. In Canada no regulator requires or audits this for material sold as a research chemical, so its quality is whatever the vendor makes it. Judge a programme on four things: which tests it runs beyond HPLC purity, whether the laboratory is accredited for those methods, whether every lot is tested rather than one batch once, and who chooses the sample sent for analysis.

A mass spectrometer and an HPLC system side by side with racks of autosampler vials
Illustration: identity and purity are different instruments answering different questions.

A single certificate answers a narrow question about one sample. A testing programme is the system that produces certificates, and it decides in advance what those certificates are able to say. This page is about evaluating that system. Checking whether one particular report is genuine is covered in how to verify a peptide COA, and reading the figures on it in what a certificate of analysis establishes.

What "third-party" does and does not mean

Third-party means the laboratory is not the manufacturer or the seller. It does not mean the arrangement is independent in every respect. In almost every case the seller chooses the laboratory, pays for the work, decides which samples to send and decides which results to publish. A laboratory can be entirely honest and the programme around it still be selective.

That is why the word on its own carries little weight. The useful questions are about the design: what is tested, by whom, on which material, and how often.

Which tests a complete programme covers

Most certificates in this market report one measurement, chromatographic purity by HPLC. It is a good measurement of a narrow thing. The tests that answer the other questions a buyer might reasonably ask are separate methods, and each one has to be commissioned on purpose.

TestQuestion it answersUsual methodWhat its absence leaves open
IdentityIs the main component the intended sequence?Mass spectrometry, ideally coupled to the separation (LC-MS)A pure sample of the wrong molecule
Chromatographic purityWhat fraction of detected material is the main peak?Reverse-phase HPLC with UV detectionHow uniform the contents are
Peptide content (assay)How much peptide is in the vial by mass?Amino acid analysis or nitrogen determinationWhether the vial holds what the label states
Counter-ion contentHow much of the solid is trifluoroacetate or another salt?Ion chromatography or fluorine NMRPart of the mass, and a possible confounder in cell work
Water contentHow much residual moisture is in the solid?Karl Fischer titrationContent accuracy and stability
Bacterial endotoxinIs lipopolysaccharide present, and how much?Limulus amebocyte lysate (LAL) or recombinant factor C assayThe contaminant most likely to confound a biological result
SterilityAre viable microorganisms present?Membrane filtration or direct inoculationA separate question from endotoxin
Residual solventsAre synthesis solvents left behind?Headspace gas chromatographySolvent carry-over from synthesis and purification
Elemental impuritiesAre heavy metals present?ICP-MSMetal contamination from reagents or equipment

Three of these deserve emphasis because their absence is the most consequential.

Identity. HPLC cannot tell one peptide from another of similar hydrophobicity. Doping-control laboratories analysing growth-promoting products from the black market found growth hormone-releasing peptides extended by a single glycine residue, identified only by high-resolution mass spectrometry (Krug and colleagues, PMID 29864719). A one-residue difference is exactly the kind a purity figure will not reveal. The HPLC and LC-MS explainer covers what each method can see.

Counter-ions. Peptides purified by reverse-phase HPLC usually leave as trifluoroacetate salts. Trifluoroacetate at low concentrations reduced proliferation in osteoblast and chondrocyte cultures, and the TFA salts of several peptides produced misleading results compared with their hydrochloride salts (Cornish and colleagues, PMID 10567002). Counter-ion content is invisible to a UV purity figure.

Endotoxin. A protein preparation marketed as lipopolysaccharide-free produced an interferon-like gene signature in bone marrow cultures that the authors attributed in part to LPS contamination (Naot and colleagues, PMID 22374965). For any work in cells or animals, endotoxin is the test most worth asking about.

Behind all of these sits a broader literature on what synthetic peptides contain besides the intended sequence: deletions, insertions, racemised residues, protecting-group adducts, oxidation products and counter-ions, along with degradation products formed later (D'Hondt and colleagues, PMID 25044089). A programme that tests only purity has chosen to look at one of those categories in aggregate.

What ISO/IEC 17025 accreditation means

ISO/IEC 17025 is the international standard for the competence of testing and calibration laboratories. Accreditation to it means an independent accreditation body has assessed the laboratory's management system, its impartiality, its method validation, the traceability of its measurements, its handling of uncertainty and its participation in proficiency testing, and continues to reassess it.

Two details change how much it tells you.

Accreditation has a scope. A laboratory is accredited for specific tests on specific types of sample, listed in a scope document. A laboratory accredited for heavy metals in food, or potency in cannabis, is not thereby accredited for peptide purity by HPLC. The question is never "is the lab accredited?" but "is this method, on this kind of material, within its accredited scope?"

Not every report from an accredited laboratory is an accredited report. Laboratories commonly run work outside their scope alongside work within it. Reports for in-scope tests usually carry the accreditation body's symbol and the laboratory's accreditation number; reports without them may describe methods that were never assessed.

### How to check accreditation in Canada

In Canada the Standards Council of Canada accredits testing laboratories and publishes a searchable directory of accredited organizations on its own website, scc-ccn.ca, where each entry links to its scope. The Canadian Association for Laboratory Accreditation also accredits laboratories in some sectors. For a laboratory abroad, find its national accreditation body; bodies that are signatories to the International Laboratory Accreditation Cooperation's mutual recognition arrangement recognise one another's accreditations. In each case, look up the laboratory by name on the accreditation body's site, open the scope, and look for the method in question. A certificate number printed on a vendor's page is a claim; the accreditation body's directory is the record.

Per-lot testing versus one-off testing

A peptide lot is one synthesis and purification run. The next lot is a separate event with its own impurity profile, its own content and its own chance of failure. A certificate from one lot says nothing reliable about another.

A programme that tested a product once, at launch, and still shows that certificate a year later has tested a lot that is probably no longer on sale. The minimum for a credible programme is a certificate for every lot, with the lot number printed on the vial so that a buyer can match the two. Better programmes repeat testing on a lot later in its shelf life, which turns a single snapshot into evidence about stability; lyophilised peptides and what degrades them explains why that matters.

Who chooses the sample

This is the weakest link in most programmes and the hardest to see from outside. If the seller selects and ships the sample, the laboratory reports on what it was sent. Nothing in that arrangement stops an unrepresentative vial from being tested, and a poorly mixed or unevenly filled lot can vary from vial to vial without any bad faith at all.

Arrangements that reduce the seller's control are stronger. They include sampling by the laboratory or an independent party, testing of vials bought anonymously from ordinary stock, testing of more than one vial per lot, and results from more than one laboratory on the same lot. A programme that publishes how its samples are obtained is making a checkable claim; most publish nothing, which usually means the seller chose.

Unflattering results are the other half of the question. A programme that only ever publishes passing certificates is either unusually consistent or not publishing everything. Ask whether failed lots are disclosed and what happens to them.

The Canadian regulatory context

Drugs in Canada are regulated under the Food and Drugs Act and the Food and Drug Regulations. Licensed drug establishments must follow Health Canada's Good Manufacturing Practices, which include testing requirements for authorised products. Material sold as a research chemical is not an authorised drug, and those requirements are written for authorised products, not for it.

The practical consequence is that no Canadian regulator sets the specification for a research-chemical vendor's testing, reviews its certificates, or audits the laboratories it chooses. Health Canada does not certify research peptides, and a vendor's testing does not make material an approved product. Whether a medicine containing a given ingredient is authorised is public record in the Drug Product Database. The wider framework is set out in Canadian rules for research peptides.

That leaves the buyer as the only auditor of a testing programme, which is the reason to evaluate one deliberately.

Questions to put to any vendor

  • Which laboratories test your lots, and are the methods you use within their accredited scope?
  • Is every lot tested, and does the lot number on the vial match the certificate?
  • Which tests are run beyond HPLC purity: identity by mass spectrometry, content, endotoxin?
  • Who selects the sample, and how is it obtained?
  • Are failed or out-of-specification lots disclosed?
  • Can each report be confirmed directly with the laboratory?

This site's lab results page lists the certificates it holds by compound and by laboratory, and the same questions apply to it. To turn the answers into a record you can compare across vendors, see the peptide COA grading checklist.

Frequently asked questions

Is third-party testing required for peptides in Canada? Not for material sold as a research chemical. Health Canada's Good Manufacturing Practices, including their testing requirements, apply to authorised drugs made by licensed establishments. A research-chemical vendor's testing is voluntary, to a specification the vendor sets, and no regulator reviews its certificates or the laboratories it chooses.

Does ISO/IEC 17025 accreditation mean a peptide result is reliable? It means an accreditation body has assessed the laboratory's competence for the specific methods listed in its scope. It helps only if the peptide method used was within that scope. Look up the laboratory in the accreditation body's directory, open the scope document, and check for the method rather than relying on a logo.

What tests should a peptide testing programme include beyond HPLC? Identity by mass spectrometry is the most important, because HPLC cannot distinguish one peptide from another. Peptide content, counter-ion and water content describe what the vial actually holds. Endotoxin matters for any biological work. Sterility, residual solvents and elemental impurities complete a fuller panel.

How can I tell whether a vendor tests every lot? Compare the lot number printed on your vial with the lot on the published certificate, and check whether certificates change as lots change. One certificate per product, unchanged for many months, indicates one-off testing. Ask the vendor directly how often new lots arrive and whether each one is tested before sale.

Why does it matter who sends the sample to the laboratory? Because the laboratory can only report on what it receives. If the seller picks the vial, nothing prevents an unrepresentative one from being tested. Sampling by an independent party, testing of anonymously purchased stock, and testing of several vials from one lot all reduce that risk.

Selected Research References

  1. D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. pubmed.ncbi.nlm.nih.gov/25044089
  2. Krug O, Thomas A, Malerød-Fjeld H, et al. Analysis of new growth promoting black market products. Growth Horm IGF Res. 2018;41:1-6. pubmed.ncbi.nlm.nih.gov/29864719
  3. Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-E783. pubmed.ncbi.nlm.nih.gov/10567002
  4. Naot D, Williams GA, Lin JM, Cornish J, Grey A. Evidence that contamination by lipopolysaccharide confounds in vitro studies of adiponectin activity in bone. Endocrinology. 2012;153(5):2076-2081. pubmed.ncbi.nlm.nih.gov/22374965

All products sold by NovaEvum are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.